Table 1.

Baseline demographics and clinical characteristics of the participants.

	Parkinson’s Disease Participants (n = 15)	Experimental Group (n = 8)	Control Group (n = 7)	T Student
Age (years)	68.13 ± 7.82	70.50 ± 9.24	65.43 ± 5.22	t = 1.280; p = 0.223
Gender (male/female)	12/3	6/2	6/1	-
Hoehn and Yahr stage	2.33 ± 0.62	2.38 ± 0.74	2.29 ± 0.49	t = 0.270; p = 0.791